Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 13/20 | 0.80 |
| ▸ | CYP11B2 | P19099 | 13/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.48 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2718952 | 0.89 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP3A4LTA4H | |
| SCHEMBL20370130 | 0.89 | CYP11B1 (0.65) | CYP11B1CYP11B2CYP3A4HPGDSLTA4H | |
| SCHEMBL2716510 | 0.88 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL2715427 | 0.85 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP3A4LDHA | |
| SCHEMBL20805529 | 0.81 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP3A4RAB9A | |
| SCHEMBL18291876 | 0.80 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP3A4HPGDSLDHA | |
| SCHEMBL1720975 | 0.80 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP3A4HPGDSLDHA | |
| SCHEMBL2717142 | 0.80 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP3A4HPGDSLDHA | |
| SCHEMBL2412899 | 0.80 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP3A4HPGDSLDHA | |
| SCHEMBL146559 | 0.80 | NPC1 (0.65) | CYP11B1CYP11B2CYP3A4LDHANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024732-B2 | Method for preparing nitrogen-containing heterocyclic compound and derivative thereof by enzymatic-chemical cascade method | NANJING TECH UNIVERSITY (CN) | 2024-07-02 | — | — | US | disclosed |
| US-12024732-B2 | Method for preparing nitrogen-containing heterocyclic compound and derivative thereof by enzymatic-chemical cascade method | NANJING TECH UNIVERSITY (CN) | 2024-07-02 | — | — | US | disclosed |
| US-20240026400-A1 | METHOD FOR PREPARING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND DERIVATIVE THEREOF BY ENZYMATIC-CHEMICAL CASCADE METHOD | NANJING TECH UNIVERSITY (CN) | 2024-01-25 | — | — | US | disclosed |
| US-20240026400-A1 | METHOD FOR PREPARING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND DERIVATIVE THEREOF BY ENZYMATIC-CHEMICAL CASCADE METHOD | NANJING TECH UNIVERSITY (CN) | 2024-01-25 | — | — | US | disclosed |
| US-20230180601-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-9966538-B2 | Compound, light-emitting element and electronic device comprising same | LMS CO., LTD. (KR) | 2018-05-08 | — | — | US | disclosed |
| CN-103214471-B | The preparation method of compound with Na-dependent glucose transporter inhibitory activity | 田边三菱制药株式会社 | 2018-02-06 | — | — | CN | disclosed |
| CN-104109155-A | Novel compounds | TANABE SEIYAKU CO | 2014-10-22 | — | — | CN | disclosed |
| CN-103819465-A | Novel compound | MITSUBISHI TANABE PHARMA CORP | 2014-05-28 | — | — | CN | disclosed |